Laboratory for Applied and Clinical Anatomy, Department of Anatomy, Histology, and Embryology, Semmelweis University, 58 Tűzoltó Street, Budapest, 1094, Hungary.
Heart and Vascular Center, Semmelweis University, 68 Városmajor Road, Budapest, 1122, Hungary.
BMC Cardiovasc Disord. 2022 Sep 4;22(1):395. doi: 10.1186/s12872-022-02826-z.
Refractory cardiogenic shock is still a major clinical challenge with high mortality rates, although several devices can be used to conquer this event. These devices have different advantages and disadvantages originating from their insertion or cannulation method, therefore many complications can occur during their use. The aim of our study was to develop and create prototypes of a novel minimal invasively insertable, transapical cannula for surgical ventricular assist devices, which uniquely incorporates the inflow and outflow routes for the blood of the patient in itself, therefore it enables the use for only one cannula for patients in cardiogenic shock.
To define the available space for the planned cannula in the left ventricle and ascending aorta, we analyzed computed tomography scans of 24 heart failure patients, who were indicated to left ventricular assist device therapy. Parallel to these measurements, hydrodynamical calculations were performed to determine the sizes of the cannulas, which were necessary to provide effective cardiac output.
After the designing steps, we produced prototypes of double-lumened, tube-in-tube apically insertable devices for three different patient groups, which included a separated venous and an arterial part using 3D modelling and printing technology. All the created cannulas are able to provide 5 l/min circulatory support.
As a result of our research we created a sizing method based on the specific analysis of computed tomography pictures of end stage heart failure patients and a cannula concept, which can provide effective antegrade flow for patients in cardiogenic shock. We believe the improved version of our tool could have a significant therapeutic role in the future after further development based on animal and in vivo tests.
尽管有几种设备可用于克服难治性心源性休克这一临床重大挑战,但仍有很高的死亡率。这些设备因其插入或插管方法的不同而具有各自的优缺点,因此在使用过程中可能会发生多种并发症。我们的研究旨在开发并创建一种新型微创可插入的经心尖外科心室辅助装置用插管的原型,该插管独特地将患者的血液流入和流出路径集成在自身中,因此可仅使用一根插管即可为心源性休克患者提供支持。
为了确定计划在左心室和升主动脉中使用的插管的可用空间,我们分析了 24 例心力衰竭患者的计算机断层扫描,这些患者均被指示接受左心室辅助装置治疗。与此同时,我们还进行了流体动力学计算,以确定提供有效心输出量所需的插管尺寸。
经过设计步骤,我们使用 3D 建模和打印技术为三组不同的患者群体生产了双腔管心尖可插入设备的原型,其中包括一个分开的静脉部分和一个动脉部分。所有创建的插管都能够提供 5 升/分钟的循环支持。
通过对终末期心力衰竭患者的计算机断层扫描图片进行特定分析和设计概念,我们创建了一种基于尺寸的方法,该方法可为心源性休克患者提供有效的前向血流。我们相信,在进一步的动物和体内测试基础上对我们的工具进行改进后,它将在未来具有重要的治疗作用。